Doctor profile · Federal record

Dr. Jascha Rubin, M.D.

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Philadelphia, PA

  • NPI 1932342185
  • Accepts Medicare
  • MIPS 92.6 / 100 · 2023
  • 11 yrs in practice
  • Male
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
207 N Broad St, Floor 6
Philadelphia, PA 191071500
(215) 561-0809
Mailing address
333 Pine St # 3F
Philadelphia, PA 191064212

Credentials & registration

NPPES · NUCC
NPI registered
April 2009 — 17 yrs on file
Profile last updated
June 2, 2015
Year of graduation
2015 — 11 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Pennsylvania #MD447056

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1932342185. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
67,855
Distinct HCPCS
10
Medicare allowed
$946,090
HCPCS Description Services Patients Avg allowed
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 36,400 51 $3
J1439 Injection, ferric carboxymaltose, 1 mg 12,000 13 $1
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj 10,260 14 $48
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg 1,970 16 $42
J0897 Injection, denosumab, 1 mg 1,920 12 $23
J1437 Injection, ferric derisomaltose, 10 mg 1,800 18 $21
J1100 Injection, dexamethasone sodium phosphate, 1 mg 690 19 $0
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 592 234 $8
J2469 Injection, palonosetron hcl, 25 mcg 370 17 $1
99215 Established patient office or other outpatient visit, 40-54 minutes 216 74 $186

In context: peer comparison

Among 59 peers in this city , average services per provider: 829. This provider delivers 82× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,089
Transactions
87
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Janssen Biotech, Inc. 11 $250.01
Novartis Pharmaceuticals Corporation 10 $249.50
Daiichi Sankyo Inc. 8 $198.88
AstraZeneca Pharmaceuticals LP 9 $182.15
Astellas Pharma US Inc 5 $163.85
Dendreon Pharmaceuticals LLC 1 $144.94
PFIZER INC. 8 $136.48
GlaxoSmithKline, LLC. 7 $136.23
Bayer Healthcare Pharmaceuticals Inc. 5 $126.50
ABBVIE INC. 3 $114.52
SOBI, INC 5 $99.55
Incyte Corporation 4 $98.64
Merck Sharp & Dohme LLC 5 $89.57
Genentech USA, Inc. 4 $89.35
GENZYME CORPORATION 2 $72.83

By nature of payment

Food and Beverage
$2,838
Education
$251

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
487
Patients
74
Total drug cost
$1,918,245
Drug Type Claims Patients Total cost
Eliquis (Apixaban) Brand 81 18 $75,547
Hydroxyurea Generic 64 15 $4,198
Anastrozole Generic 45 15 $2,195
Revlimid (Lenalidomide) Brand 34 0 $619,003
Xarelto (Rivaroxaban) Brand 33 0 $39,363
Acyclovir Generic 29 0 $415
Jakafi (Ruxolitinib Phosphate) Brand 29 0 $501,163
Oxycodone Hcl Generic 29 0 $823
Dexamethasone Generic 27 15 $1,079
Hizentra (Immun Glob G(Igg)/Pro/Iga 0-50) Brand 24 0 $90,356

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Jascha Rubin's medical specialty?
Dr. Jascha Rubin practices Hematology & Oncology Physician in Philadelphia, PA.
Where does Dr. Jascha Rubin practice?
Dr. Jascha Rubin practices at 207 N Broad St, Philadelphia, PA 191071500. Office phone: 2155610809.
What is Dr. Jascha Rubin's NPI?
Dr. Jascha Rubin's National Provider Identifier (NPI) is 1932342185, issued by NPPES.
Does Dr. Jascha Rubin accept Medicare assignment?
Yes. Dr. Jascha Rubin accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jascha Rubin commonly perform?
Top Medicare-reported procedures in 2023: Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144). Source: CMS Medicare Physician & Other Practitioners file.